Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study

Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study

Abstract Objectives Our objective was to investigate the effectiveness and safety of silodosin in patients with benign prostatic hyperplasia (BPH) who switched to silodosin from another α1 blocker because of inadequate response. Methods This was a prospective observational study conducted at 715 med...

Full description

Bibliographic Details
Main Authors: Hiroshi Takahashi, Shinichi Kubono, Takehiko Taneyama, Kiyotoshi Kuramoto, Hideki Mizutani, Noriko Tanaka, Masaki Yoshida
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-01-01
Series:Drugs in R&D
Online Access:http://link.springer.com/article/10.1007/s40268-018-0258-4

Internet

http://link.springer.com/article/10.1007/s40268-018-0258-4

Similar Items